Notice Information
Notice Title
NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections
Notice Description
Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.
Lot Information
Lot 1
Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.
Procurement Information
Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Western Health and Social Care Trust requires the purchase of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections which are subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-049390
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/027072-2024
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,532,303 £1M-£10M
Notice Dates
- Publication Date
- 23 Aug 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 15 Aug 20241 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- WESTERN HEALTH AND SOCIAL CARE TRUST
- Contact Name
- Not specified
- Contact Email
- Not specified
- Contact Phone
- Not specified
Buyer Location
- Locality
- Not specified
- Postcode
- Not specified
- Post Town
- Not specified
- Country
- Not specified
-
- Major Region (ITL 1)
- Not specified
- Basic Region (ITL 2)
- Not specified
- Small Region (ITL 3)
- Not specified
- Delivery Location
- TLN Northern Ireland
-
- Local Authority
- Not specified
- Electoral Ward
- Not specified
- Westminster Constituency
- Not specified
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-049390-2024-08-23T13:01:14+01:00",
"date": "2024-08-23T13:01:14+01:00",
"ocid": "ocds-h6vhtk-049390",
"initiationType": "tender",
"tender": {
"id": "WT2024-11, WT2024-12, WT2024-13",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.",
"lots": [
{
"id": "1",
"description": "Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKN"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_PROTECT_RIGHTS",
"description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights"
}
],
"procurementMethodRationale": "Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Western Health and Social Care Trust requires the purchase of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections which are subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists."
},
"awards": [
{
"id": "027072-2024-WT2024-11, WT2024-12, WT2024-13-1",
"relatedLots": [
"1"
],
"title": "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections",
"status": "active",
"suppliers": [
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
]
}
],
"parties": [
{
"id": "GB-FTS-54496",
"name": "Western Health and Social Care Trust",
"identifier": {
"legalName": "Western Health and Social Care Trust",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"locality": "Londonderry",
"region": "UKN0",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Bronagh Hegarty",
"telephone": "+44 2871345171",
"email": "Bronagh.Hegarty@westerntrust.hscni.net"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://westerntrust.hscni.net/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"identifier": {
"legalName": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"id": "00119006",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "2nd Floor, The Westworks Building White City Place, 195 Wood Lane",
"locality": "London",
"region": "UKI",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-54496",
"name": "Western Health and Social Care Trust"
},
"contracts": [
{
"id": "027072-2024-WT2024-11, WT2024-12, WT2024-13-1",
"awardID": "027072-2024-WT2024-11, WT2024-12, WT2024-13-1",
"title": "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections",
"status": "active",
"value": {
"amount": 1532303.9,
"currency": "GBP"
},
"dateSigned": "2024-08-16T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}